Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3875472rdf:typepubmed:Citationlld:pubmed
pubmed-article:3875472lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:3875472lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:3875472lifeskim:mentionsumls-concept:C0076079lld:lifeskim
pubmed-article:3875472lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:3875472lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:3875472pubmed:dateCreated1985-10-22lld:pubmed
pubmed-article:3875472pubmed:abstractText120 consecutive clinical isolates of various species of Enterobacteriaceae and 30 consecutive clinical isolates of Haemophilus influenzae (including 5 which produced beta-lactamase) were assessed for susceptibility to temocillin using a broth microdilution technique and both 'light' (10(3) CFU/ml) and 'heavy' (10(6) CFU/ml) inocula. At the lighter inoculum, 90% of the Enterobacteriaceae were inhibited by temocillin at a concentration of 4 mg/L. 90% of the H. influenzae were similarly inhibited at a concentration of 0.5 mg/L, and no differences were observed between producers and non-producers of beta-lactamase. At the heavier inoculum, a significant inoculum effect was observed: minimum inhibitory concentrations (MICs) increased up to 128-fold for H. influenzae and somewhat less than that for the Enterobacteriaceae. Klebsiella pneumoniae was least affected by inoculum, showing only a 2- to 4-fold increase in the MIC. It is concluded that temocillin is active in vitro against the species tested and warrants further clinical trial.lld:pubmed
pubmed-article:3875472pubmed:languageenglld:pubmed
pubmed-article:3875472pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875472pubmed:citationSubsetIMlld:pubmed
pubmed-article:3875472pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875472pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875472pubmed:statusMEDLINElld:pubmed
pubmed-article:3875472pubmed:issn0012-6667lld:pubmed
pubmed-article:3875472pubmed:authorpubmed-author:ChadwickM VMVlld:pubmed
pubmed-article:3875472pubmed:authorpubmed-author:GayaHHlld:pubmed
pubmed-article:3875472pubmed:authorpubmed-author:HutchinsonG...lld:pubmed
pubmed-article:3875472pubmed:issnTypePrintlld:pubmed
pubmed-article:3875472pubmed:volume29 Suppl 5lld:pubmed
pubmed-article:3875472pubmed:ownerNLMlld:pubmed
pubmed-article:3875472pubmed:authorsCompleteYlld:pubmed
pubmed-article:3875472pubmed:pagination15-7lld:pubmed
pubmed-article:3875472pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3875472pubmed:meshHeadingpubmed-meshheading:3875472-...lld:pubmed
pubmed-article:3875472pubmed:meshHeadingpubmed-meshheading:3875472-...lld:pubmed
pubmed-article:3875472pubmed:meshHeadingpubmed-meshheading:3875472-...lld:pubmed
pubmed-article:3875472pubmed:meshHeadingpubmed-meshheading:3875472-...lld:pubmed
pubmed-article:3875472pubmed:meshHeadingpubmed-meshheading:3875472-...lld:pubmed
pubmed-article:3875472pubmed:year1985lld:pubmed
pubmed-article:3875472pubmed:articleTitleIn vitro activity of temocillin against gram-negative clinical isolates.lld:pubmed
pubmed-article:3875472pubmed:publicationTypeJournal Articlelld:pubmed